An Observational Study of Patients With Chronic Gastrointestinal Disease

Target PharmaSolutions

Status

Active, not recruiting

Conditions

Gastrointestinal Diseases

Treatments

Other: Observational

Study type

Observational

Funder types

Industry

Identifiers

NCT05774080

TARGET-GASTRO

Details and patient eligibility

About

TARGET-GASTRO is an observational research study to conduct a comprehensive review of outcomes for patients with the chronic gastrointestinal (GI) diseases: eosinophilic gastrointestinal disease (EGID), ulcerative colitis (UC) or Crohn's disease (CD).

Enrollment

500,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Disease Cohort

Inclusion Criteria:

Adult* patients at the time of enrollment with a diagnosis or major symptom of EGIDs, UC, or CD by ICD-10 code in the EHR interface

Exclusion Criteria:

Death
Manual removal (sponsor or site request)
No EHR interface encounter > 3 years.

Engaged Cohort

Inclusion Criteria:

Adult* patients diagnosed and managed for these conditions invited to participate
Ability to provide written informed consent

Exclusion Criteria:

Patient expressed desire to withdraw consent to complete PROs
Failure to complete PROs within 24 weeks of initial invitation
Greater than 24 months lapse of survey completion after baseline surveys completed
Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort.